Institution statistics

LEIDS UNIVERSITAIR MEDISCH CENTRUM - Netherlands 

Ranking results:

Past rankings:
2019
Criterium:Position:
Overall Score:100-200
Total Project Funding per Partner:100-200
Total Number of Projects:100-200
Ranking timeline:

European project participation (2000-01-01 - 2020-12-31 ):

Performance:

Funding:

Total funding allocated to projects this organisation participated or coordinated

Funding per Partner:

Since 2014 individual funding per partner. If data is not available at CORDIS: total funding / No of participants.

Projects:
Leadership:

Total number of projects: 342
As coordinator: 49
As participant: 265
Sole participant: 28
Coordinator / Participant Ratio: 0.18*

*Ratio includes only projects with > 2 partners

Summary:
Total project funding [€]:Projects [No]:
Year:coordinator*participant*per partner  as coordinatoras participant
2020 7.080.486 265.905.603 4.695.433 4 18
2019 24.007.427 183.976.524 14.323.634 8 14
2018 10.302.943 133.851.105 531.240 8 8
2017 2.520.473 80.797.539 0 2 16
2016 22.629.460 237.662.320 0 4 20
2015 20.858.519 100.924.609 0 7 17
2014 6.416.548 19.998.649 0 3 4
2013 14.282.850 169.680.467 6.263.444 6 18
2012 24.563.139 91.270.686 7.451.087 8 16
2011 18.085.923 119.079.884 0 3 18
2010 4.357.784 91.858.036 0 4 12
2009 2.858.188 61.733.738 5.253.525 1 10
2008 14.140.284 108.140.619 8.220.227 2 19
2007 17.350.000 11.472.782 1.597.089 3 3
2006 15.429.959 125.586.095 8.528.384 4 25
2005 5.705.974 97.340.099 6.008.172 3 18
2004 5.711.789 115.185.066 5.657.896 6 19
2003 0 400.000 66.667 1
2002 0 7.630.882 1.023.762 5
2001 0 2.397.490 732.524 2
2000 208.590 3.899.803 537.439 1 2
*n.b.: These numbers represent the total amount of funds allocated to projects this institution has participated in, not the funding allocated to this institution

Networking:

Partners:
Institution:Projects [No]:
KAROLINSKA INSTITUTE9
FRAUNHOFER GESELLSCHAFT ZUR FOERDERUNG DER ANGEWANDTEN FORSCHUNG E V8
EUROPEAN MOLECULAR BIOLOGY LABORATORY7
THE CHANCELLOR MASTERS AND SCHOLARS OF THE UNIVERSITY OF OXFORD7
UNIVERSITY OF COPENHAGEN7
CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE6
EBERHARD KARLS UNIVERSITAET TUEBINGEN6
ERASMUS UNIVERSITAIR MEDISCH CENTRUM ROTTERDAM6
INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE6
PERCUROS BV6
THE CHANCELLOR MASTERS AND SCHOLARSOF THE UNIVERSITY OF CAMBRIDGE6
CHARITE UNIVERSITAETSMEDIZIN BERLIN5
JOHANN WOLFGANG GOETHE UNIVERSITAET FRANKFURT5
KATHOLIEKE UNIVERSITEIT LEUVEN5
SANOFIAVENTIS5
UNIVERSITEIT ANTWERPEN5
UNIVERSITY OF DUNDEE5
UNIVERSITY OF HELSINKI5
UNIVERSITY OF NEWCASTLE UPON TYNE5
UNIVERSITY OF WALES CARDIFF5
UPPSALA UNIVERSITET5
BOEHRINGER INGELHEIM PHARMA GMBH &CO KG4
COMMISSARIAT A L'ENERGIE ATOMIQUE4
CONSEJO SUPERIOR DE INVESTIGACIONES CIENTIFICAS4
ECRIN EUROPEAN CLINICAL RESEARCH INFRASTRUCTURE NETWORK4
INSTITUT NATIONAL DE RECHERCHE POUR L'AGRICULTURE L'ALIMENTATION ET L'ENVIRONNEMENT4
JANSSEN PHARMACEUTICA NV4
KING'S COLLEGE LONDON4
PFIZER LIMITED4
SORBONNE UNIVERSITE4
STICHTING KATHOLIEKE UNIVERSITEIT4
TECHNISCHE UNIVERSITAET MUENCHEN4
THE PROVOST FELLOWS AND SCHOLARS OF THE COLLEGE OF THE HOLY AND UNDIVIDED TRINITY OF QUEEN ELIZABETH NEAR DUBLIN HEREINAFTER TRINITY COLLEGE DUBLIN4
THE UNIVERSITY OF MANCHESTER4
UNIVERSITAET BERN4
UNIVERSITAT DE BARCELONA4
UNIVERSITY OF OSLO4
UNIVERSITY OF TAMPERE4
ACADEMIC MEDICAL CENTRE AMSTERDAM3
ASTRAZENECA3
AUSTRIAN RESEARCH CENTERS SIEBERDORF3
CONSIGLIO NAZIONALE DELLE RICERCHE3
CONSORCI INSTITUT D'INVESTIGACIONS BIOMEDIQUES AUGUST PI I SUNYER3
DANMARKS TEKNISKE UNIVERSITET3
EATRIS ERIC3
ECOLE POLYTECHNIQUE FEDERALE DE LAUSANNE3
GSF FORSCHUNGSZENTRUM FUER UMWELT UND GESUNDHEIT3
HEINRICHHEINEUNIVERSITAET DUESSELDORF3
IMPERIAL COLLEGE OF SCIENCE TECHNOLOGY AND MEDICINE3
INSTITUTO DE SALUD CARLOS III3
ISTITUTO SUPERIORE DI SANITA3
MEDIZINISCHE UNIVERSITAT INNSBRUCK3
NOVARTIS PHARMA3
RUPRECHT KARLS UNIVERSITAET HEIDELBERG3
TECOBIOSCIENCES3
THE UNIVERSITY OF LIVERPOOL3
THE UNIVERSITY OF SHEFFIELD3
UNIVERSIDAD AUTONOMA DE MADRID3
UNIVERSITAET KARLSRUHE3
UNIVERSITAIR MEDISCH CENTRUM UTRECHT3
UNIVERSITE DU LUXEMBOURG3
UNIVERSITE LOUIS PASTEUR STRASBOURG 13
UNIVERSITEIT MAASTRICHT3
UNIVERSITY COLLEGE LONDON3
UNIVERSITY OF GLASGOW3
ABBVIE INC2
BIOBANKS AND BIOMOLECULAR RESOURCES RESEARCH INFRASTRUCTURE CONSORTIUM2
CENTRE HOSPITALIER UNIVERSITAIRE VAUDOIS2
CSC TIETEEN TIETOTEKNIIKAN KESKUS OY2
DANISH CANCER SOCIETY2
DRESDEN UNIVERSITY OF TECHNOLOGY2
EIDGENOESSISCHE TECHNISCHE HOCHSCHULE ZUERICH2
ELI LILLY AND COMPANY LIMITED2
EUROPEAN INFRASTRUCTURE OF OPEN SCREENING PLATFORMS FOR CHEMICAL BIOLOGY EUROPEAN RESEARCH INFRASTUCTURE CONSORTIUM2
EUROPEAN ORGANISATION FOR RESEARCH AND TREATMENT OF CANCER AISBL2
F HOFFMANNLA ROCHE2
FFUND BV2
FONDAZIONE CENTRO SAN RAFFAELE DEL MONTE TABOR2
FONDAZIONE TELETHON2
FORSCHUNGSZENTRUM JULICH2
FUNDACAO D ANNA SOMMER CHAMPALIMAUD E DR CARLOS MONTEZ CHAMPALIMAUD2
FUNDACIO INSTITUT MAR D INVESTIGACIONS MEDIQUES IMIM2
FUNDACIO PRIVADA CLINIC PER A LA RECERCA BIOMEDICA2
GEORG SPEYER HAUS CHEMOTHERAPEUTISCHES FORSCHUNGSINSTITUT2
GOETEBORGS UNIVERSITET2
HELMHOLTZZENTRUM FUR INFEKTIONSFORSCHUNG2
IMAGINE INSTITUT DES MALADIES GENETIQUES NECKER ENFANTS MALADES FONDATION2
INFORMATION TECHNOLOGY FOR TRANSLATIONAL MEDICINE2
INFRAFRONTIER2
INSTITUT DE RECHERCHES SERVIER2
INSTITUT PASTEUR2
INSTITUTO DE MEDICINA MOLECULAR JOAO LOBO ANTUNES2
INSTRUCTERIC2
JDRF INTERNATIONAL2
KONINKLIJKE NEDERLANDSE AKADEMIE VAN WETENSCHAPPEN KNAW2
KUNGLIGA TEKNISKA HOEGSKOLAN2
LEIDEN UNIVERSITY2
LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE ROYAL CHARTER2
LUDWIG MAXIMILIANS UNIVERSITAET MUENCHEN2
LUNDS UNIVERSITET2
Constancy:

Total number of partners:910

Partner loyalty:
Frequent Partner: (> 2 projects): 273
Rare Partner: 637

Frequent / Rare Partner Ratio: 0.43

Diversity:

Categories:
Category:No:
BIOLOGICAL SCIENCES7
RTD HORIZONTAL TOPICS3
SOCIAL AND ECONOMIC CONCERNS2
AGRICULTURE AND MARINE RESOURC1

Project overview:

Start dateProjectacronymrolefundingpartners
2020-10-01Immunological incompatibility as a basis for cancer curing and vaccination ULISESparticipant2.977.16010
2020-09-01Towards effective radiation protection based on improved scientific evidence and social considerations - focus on radon and NORM RadoNormparticipant18.000.00056
2020-09-01Assessing cardiac Contractility and Quantification of Underlying mechanisms In vitro via Response in Excitation-contraction coupling ACQUIREcoordinator150.0001
2020-09-01Biosafety assays for the diagnosis and prediction of drug-related complement pathology Biosafetyparticipant900.0006
2020-06-01DESIGN STUDY FOR A EUROPEAN VACCINE INFRASTRUCTURE TRANSVAC-DSparticipant1.879.21625
2020-05-01Staff Exchange for Novel applications in 19f magnetic resonance imaging SENATORparticipant1.541.00011
2020-05-01EUbOPEN: Enabling and Unlocking biology in the OPEN EUbOPENparticipant27.935.00022
2020-05-01Translational approaches to disease modifying therapy of type 1 diabetes - HARVESTing the fruits of INNODIA INNODIA HARVESTparticipant5.999.05540
2020-04-01Prevention of SARS-CoV-2 infection through development and clinical testing of a novel Virus Like Particle (VLP) vaccine Prevent-nCoVparticipant2.728.3406
2020-04-01proactive monitoring of cancer as an alternative to surgery PRISAR2participant2.484.00025
2020-04-01Human Brain Project Specific Grant Agreement 3 HBP SGA3participant150.000.000131
2020-04-01Indo-European Consortium for Next Generation Influenza Vaccine Innovation INCENTIVEparticipant9.974.29419
2020-03-01Critical solutions for elderly well-being RISE-WELLcoordinator2.691.2797
2020-03-01Advancing Innovative Stem Cell-based Therapy for Diabetes in Europe ISLETparticipant7.999.9997
2020-02-01Novel Applications in 19F Magnetic Resonance Imaging NOVA-MRIcoordinator4.051.63412
2020-02-01Selection of human iPSC-derived cardiomyocytes by sinGle cell geNe expression and pAtch clamp for a maTUre caRdiac modEl SiGNATUREcoordinator187.5721
2020-01-01A novel Stratified Medicine Algorithm to predict treatment responses to host-directed therapy in TB patients. SMA-TBparticipant6.388.1049
2020-01-01Human Cell Atlas of the Pancreas ESPACEparticipant4.962.49510
2020-01-01Automated Cellular Robot-Assisted Technologies for translation of discovery-led research in Osteoarthritis AutoCRATparticipant7.452.7709
2020-01-01GROUP CARE FOR THE FIRST 1000 DAYS (GC_1000): If it takes a village to raise a child, group care is the first step GC_1000participant3.999.99810
2020-01-01Multidisciplinary Training in Chronic Kidney Disease: from genetic modifiers to drug discovery TrainCKDisparticipant4.017.84811
2020-01-01Brain Involvement iN Dystrophinopathies BINDparticipant6.666.32519
2019-12-01RAtional design of canceR ImmunoTherapY: one size does not fit all RARITYcoordinator1.499.7951
2019-12-01Immune Safety Avatar: nonclinical mimicking of the immune system effects of immunomodulatory therapies imSAVARparticipant10.999.31628
2019-11-01Identifying Digital Endpoints to Assess FAtigue, Sleep and acTivities in daily living in Neurodegenerative disorders and Immune-mediated inflammatory diseases IDEA-FASTparticipant20.997.52346
2019-11-01Active Monitoring of Cancer As An Alternative To Surgery CASTcoordinator4.111.55413
2019-10-01A nanovaccine Approach for the treatment of Pancreatic Cancer PAVEparticipant4.023.61715
2019-10-01Site-selective protein-modification chemistries for antibody-drug conjugates (ADCs) SIMICAparticipant800.0005
2019-09-01The circadian clock in day-active species: preserving our health in modern society DiurnalHealthcoordinator2.233.2511
2019-08-01TArgeTed molecular Imaging and surgery for gastro-intestinal Cancer TAcTICcoordinator150.0002
2019-06-01Vaccine Against Schistosomiasis for Africa. A Phase I clinical study of the SchistoShield® anti-schistosomiasis vaccine in adults in endemic areas of sub-Saharan Africa VASAparticipant6.619.34210
2019-05-01Defining the antithrombin measurand: role of proteoforms in harmonisation of diagnostic tests in thrombosis HarmonizATformscoordinator187.5721
2019-05-01Progress novel assets (one FIH start) for non-tubercular mycobacteria that may act synergistically with bedaquiline and cytochrome bc drugs RespiriNTMcoordinator5.687.9849
2019-05-01Progress new assets (one pre-new molecular entity and one first-time-in-human start) for tuberculosis that act synergistically with bedaquiline, cytochrome bc or cytochrome bd inhibitors RespiriTBcoordinator6.840.0009
2019-05-01INnate-ImmunomeTabolIsm as Antiviral TargEt INITIATEparticipant4.054.10614
2019-04-01Biomarkers in Atopic Dermatitis and Psoriasis BIOMAPparticipant10.500.00032
2019-03-01Providing an open collaborative space for digital biology in Europe EOSC-Lifeparticipant23.745.99646
2019-03-01Establishing the molecular fundamentals of arthritic diseases – a step forward to Heal Arthritis ArthritisHealcoordinator3.297.27117
2019-02-01Ensuring long-term sustainability of excellence in chemical biology within Europe and beyond EU-OPENSCREEN-DRIVEparticipant4.999.56434
2019-01-01MICROBiome-based biomarkers to PREDICT decompensation of liver cirrhosis and treatment response MICROB-PREDICTparticipant15.000.00022
2019-01-01Induced pluripotent stem cell-based therapy for spinal regeneration iPSpineparticipant14.959.78121
2019-01-01European Joint Programme on Rare Diseases EJP RDparticipant55.073.83189
2019-01-01Training network in drug discovery targeting TRIM Ubiquitin ligases in disease TRIM-NETparticipant3.203.44814
2019-01-01Investigating Mechanisms and Models Predictive of Accessibility of Therapeutics (IM2PACT) Into The Brain IM2PACTparticipant9.000.00027
2018-12-01Interdisciplinary training network for advancing Organ-on-a-chip technology in Europe EUROoCparticipant3.942.86121
2018-12-01Attempts to Control the End of Life in People with Dementia: Two-level Approach to Examine Controversies CONT-ENDcoordinator1.988.9721
2018-11-01Developing novel tools and technologies to assess the safety and efficacy of cell-based regenerative medicine therapies, focusing on kidney disease RenalToolBoxparticipant4.071.17614
2018-09-01Tracers for targeting nerves in the autonomic nervous system AUTO NERVEcoordinator140.0001
2018-09-01Nanoparticle-Based Therapeutic Applications and Detection of Carbon Monoxide Releasing Molecules ACORNparticipant1.000.0006
2018-09-01Elucidating Mechanisms of Bladder Cancer Metastasis EMBRACEcoordinator177.5991

overview shows latest 50 from 342 projects (2000-01-01 - 2020-12-31)
A full list of projects can be found here:

Alias institution names:
  • ACADEMISCH ZIEKENHUIS LEIDEN
  • ACADEMISCH ZIEKENHUIS LEIDEN ACTING UNDER THE NAME LEIDEN UNIVERSITY MEDICAL CENTER
  • ACADEMISCH ZIEKENHUIS LEIDEN ACTING UNDER THE NAME LEIDS UNIVERSITAIR MEDISCH CENTRUM
  • LEIDEN UNIVERSITY MEDICAL CENTER
  • LEIDEN UNIVERSITY MEDICAL CENTRE
  • LEIDS UNIVERSITAIR MEDISCH CENTRUM

Data provision: © European Union; Source: CORDIS, http://cordis.europa.eu/ | This page is not provided by the European Commission see:Impressum